The Price-to-Earnings ratio is the single most quoted valuation metric on the Dhaka Stock Exchange — and the most frequently misunderstood. Every day, traders reference P/E without asking the question that matters: P/E compared to what?
This article breaks down what the P/E ratio actually measures, how to calculate it, what ranges are normal for different DSE sectors, and when the number is misleading.
What the P/E Ratio Measures
The P/E ratio answers a simple question: how many years of current earnings are investors willing to pay for a stock?
The formula:
P/E Ratio = Market Price per Share / Earnings per Share (EPS)
A stock trading at BDT 266 with an EPS of BDT 22.80 has a P/E of 11.7x. That means investors are paying 11.7 times one year’s earnings for each share.
A higher P/E suggests the market expects earnings to grow. A lower P/E suggests slower growth expectations — or that the stock is undervalued. Context determines which interpretation is correct.
Real DSE Examples
Let us apply this to four of the most widely held stocks on the DSE, using trailing twelve-month data as of early March 2026.
| Stock | Ticker | Price (BDT) | EPS (BDT) | Trailing P/E | Sector |
|---|---|---|---|---|---|
| Grameenphone | GP | 266.10 | 22.80 | 11.7x | Telecom |
| Square Pharma | SQURPHARMA | 227.90 | 29.27 | 7.8x | Pharmaceuticals |
| BRAC Bank | BRACBANK | 67.10 | 8.28 | 8.1x | Banking |
| Beximco Pharma | BXPHARMA | 114.80 | 15.58 | 7.4x | Pharmaceuticals |
The overall DSEX market P/E currently sits near 10x, having recovered from the 9.5x level recorded in March 2025.
Notice that all four blue-chips trade below or near the broad market average. That alone does not make them cheap — it means we need to compare within sectors, not across the entire index.
Sector P/E Ranges on the DSE
Different sectors carry structurally different P/E ranges because their growth profiles, capital requirements, and risk characteristics differ.
| Sector | Typical P/E Range | Why |
|---|---|---|
| Banking | 6x – 12x | Regulated margins, high NPL risk, cyclical earnings |
| Pharmaceuticals | 8x – 20x | Steady domestic demand, export upside, branded generics |
| Telecom | 10x – 18x | Subscription revenue, high capex, regulatory pressure |
| Cement / Engineering | 8x – 15x | Infrastructure-driven, cyclical demand |
| Textiles / RMG | 5x – 10x | Export-dependent, margin volatility, FX exposure |
A banking stock at 8x is mid-range for its sector. A pharma stock at 8x is at the low end of its range — which may signal undervaluation or deteriorating fundamentals. The sector context changes the interpretation entirely.
When P/E Is Misleading
The P/E ratio breaks down in several common situations on the DSE:
Cyclical stocks at peak earnings. A cement company reporting record profits during an infrastructure boom may show a P/E of 5x. That looks cheap — until the cycle turns and EPS drops 40-50%, pushing the P/E to 10x or higher without the price moving at all. Low P/E on cyclicals can be a sell signal, not a buy signal.
Loss-making companies. If EPS is negative, the P/E ratio is undefined. Several DSE-listed companies trade at negative earnings. For stocks with negative earnings — like the Z-category paradox case study — P/E simply doesn’t compute. These situations require looking at book value, sector context, and speculative mechanics instead. Screening by “lowest P/E” will never surface these stocks, which means your screen has a blind spot.
One-time gains or charges. A company that sold land or received a legal settlement may report inflated EPS for one quarter. The trailing P/E drops artificially. Always check whether earnings are recurring or one-off.
Stocks with minimal float. Some DSE-listed stocks have extremely thin free float. The price may not reflect fair value because there is no liquidity to enforce it. A P/E of 3x on a stock that trades BDT 50,000 per day is not a value opportunity — it is a liquidity trap.
Trailing P/E vs Forward P/E
Most P/E figures quoted on DSE data portals — including dsebd.org — use trailing earnings: the last four reported quarters of EPS. This is backward-looking.
Forward P/E uses analyst estimates for the next twelve months of earnings. For example, Grameenphone’s trailing P/E is 11.7x, but its forward P/E is closer to 10.1x, reflecting expected earnings growth.
Forward P/E is more useful for investment analysis but harder to find for DSE stocks because analyst coverage in Bangladesh remains limited. For most investors, trailing P/E with a manual adjustment for known earnings trends is the practical approach.
How to Use P/E in Practice
The P/E ratio is a starting point, not a conclusion. A disciplined approach:
- Compare within the sector, not across the index. A bank at 8x and a pharma at 8x are in very different positions relative to their peers.
- Check the earnings trend. Is EPS growing, flat, or declining? A rising P/E on rising earnings is different from a rising P/E on falling prices.
- Pair with other metrics. P/E alone misses balance sheet risk. Combine it with NAV (net asset value), debt-to-equity, and dividend yield for a fuller picture.
- Watch the market P/E. When the DSEX-wide P/E drops below 10x, history suggests the broad market is trading at a discount to its long-term average. That does not guarantee a rally — but it establishes context.
The P/E ratio is one lens. Used correctly — with sector context, earnings quality checks, and complementary metrics — it is a powerful one.
This content is for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Past performance does not guarantee future results. Consult a BSEC-registered financial advisor before making investment decisions.